Edit |   |
---|---|
Product Name | EPZ5676 |
Description | A highly potent and selective inhibitor of DOT1L histone methyltransferase activity (Ki = 80 pM); inhibits the H3K79 methylation in various human leukemia cell lines (IC50s = 3-5 nM), decreasing MLL-fusion target gene expression and inhibiting proliferation; intravenous infusion of EPZ-5676 at a dose of 35 mg/kg can regress tumors in a rat xenograft model of MLL-rearranged leukemia |
Size | 25 mg |
Concentration | n/a |
Applications | n/a |
Other Names | 1380288-88-9 inhibitors DOT1L histones methyltransferases MLL-rearranged leukemias epigenetics inhibits inhibitions EPZ5676 EPZ 5676 DOT1L domains genes DNA damages repairs cells cycles regulations MLL drugs aminonucleosides expressions translocations intravenous infusions tumors regression rats xenografts EPZ-5676 potent selective H3K79 |
Gene, Accession, CAS # | CAS: 1380288-87-8 |
Catalog # | 16175-25 |
Price | $479.00 |
Order / More Info | EPZ5676 from CAYMAN CHEMICAL COMPANY |
Product Specific References | n/a |